ArticleCancer communications (London, England)2022

miR-99a-5p modulates doxorubicin resistance via the COX-2/ABCG2 axis in triple-negative breast cancer: from the discovery to in vivo studies.

Iris Garrido-Cano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.